Announcements Trials
Browse Landscape

Status

Completed 6Withdrawn 1Terminated 1Recruiting 1

Sponsor Class

OTHER 40INDUSTRY 9NETWORK 3NIH 2UNKNOWN 1

Study Type

Interventional 31Observational 9

Sponsor

Cancer Type

Thoracic 3Breast 2Other hematologic neoplasm 1Myeloid 1Head & Neck 1Genitourinary 1

Conditions

Neoplasms 3Carcinoma, Non-Small-Cell Lung 3Breast Neoplasms 2Prostatic Hyperplasia 1Neoplasm Metastasis 1Lung Neoplasms 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1Leiomyoma 1Hyperthermia 1Head and Neck Neoplasms 1Arteriovenous Malformations 1

Interventions

Blood Specimen Collection 31Sorafenib 29Nivolumab 29Bevacizumab 26Data Collection 24Observation 23palbociclib 22Sunitinib 22radium Ra 223 dichloride 20enzalutamide 18Rituximab 18Ipilimumab 16regorafenib 15Drug Therapy 15Trastuzumab 14Docetaxel 14ribociclib 12exemestane 12atezolizumab 12Standard of Care 12darolutamide 11apalutamide 11Leuprolide 11Capecitabine 11Afatinib 11Bortezomib 10Anastrozole 10trastuzumab deruxtecan 9pembrolizumab 9avelumab 9

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

9 trials
RecentStart dateEnrollment
INDUSTRY × Observational × Therapeutics × Clear all
NCT06448793 2025-12-04

Patient and Physician Preference Study in Resectable, Non-small Cell Lung Cancer Treatments

Bristol-Myers Squibb

Recruiting
55 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT04272216 2025-09-09

RAVI Registry

Terumo Medical Corporation

Completed
99 enrolled 15 charts
Genitourinary

Arteriovenous Malformations, Leiomyoma, Prostatic Hyperplasia

NCT02392455 2025-07-28

VARGADO - Vargatef in 2nd-line Therapy of Non-Small Cell Lung Cancer (NSCLC)

Boehringer Ingelheim

Completed
817 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT05619978 2022-11-17

French Study to Highlight the Unmet Treatment Needs of 3L+ CP-CML and With T315I-mutated CML Patients

Novartis

Completed
200 enrolled
MyeloidOther hematologic neoplasm

Leukemia, Myelogenous, Chronic, BCR-ABL Positive

NCT02896049 2021-07-27

Celsius TCS Hyperthermia System PMCF Trial

Celsius42 GmbH

Withdrawn

Hyperthermia, Neoplasms

NCT03761901 2020-05-08

REVEAL

AstraZeneca

Completed
141 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Neoplasm Metastasis

NCT01357863 2018-09-14

(TYCO1)

GlaxoSmithKline

Terminated
3 enrolled
Breast

Breast Neoplasms, Neoplasms

NCT01160094 2016-03-28

TYCO

Novartis

Completed
288 enrolled
Breast

Breast Neoplasms, Neoplasms

NCT01080313 2012-02-13

LORHAN

Eli Lilly and Company

Completed
26,000 enrolled
Head & Neck

Head and Neck Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡